Literature DB >> 3493940

Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration.

S E Raper, S J Burwen, M E Barker, A L Jones.   

Abstract

To determine the fate of exogenous epidermal growth factor (EGF) in regenerating liver, 125I-labeled EGF was injected into rat portal veins at various times after 70% hepatectomy. Epidermal growth factor was taken up by the liver remnant at all time points studied (0, 4, 8, 16, and 36 h), but at 8 h after hepatectomy a large quantity was retained by the liver and EGF degradation products appearing in the bile decreased markedly. Electron microscopic autoradiography of the regenerating livers 1 h after injection of 125I-EGF demonstrated that 27% of the grains were associated with hepatocyte nuclei compared to 0.5% in shamoperated controls. There was also a concomitant decrease in grains associated with the lysosomal compartment. Nuclei isolated from regenerating livers exposed to 125I-EGF also demonstrated a three-fold increase in radioactivity compared to nuclei from control livers. Nearly 70% of nuclear radioactivity was precipitable with a specific antibody to EGF, and a small fraction appeared to be part of a high molecular weight complex. These data support the hypothesis that during the pre-S phase of liver regeneration, EGF is translocated to the nucleus rather than to lysosomes, and may participate in the initiation of deoxyribonucleic acid synthesis or alteration of gene expression.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493940     DOI: 10.1016/s0016-5085(87)91084-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

1.  SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells.

Authors:  Sayed Hossein Hashemi; Jia-Yi Li; Håkan Ahlman; Annica Dahlström
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  New concepts in liver regeneration.

Authors:  Kimberly J Riehle; Yock Y Dan; Jean S Campbell; Nelson Fausto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

3.  From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways.

Authors:  Enzo Ierardi; Rosa Rosania; Mariangela Zotti; Floriana Giorgio; Simonetta Prencipe; Nicola Della Valle; Vincenzo De Francesco; Carmine Panella
Journal:  World J Gastrointest Oncol       Date:  2010-06-15

4.  Growth factors and the liver.

Authors:  A C Selden; H J Hodgson
Journal:  Gut       Date:  1991-06       Impact factor: 23.059

Review 5.  Liver regeneration in relationship to acute liver failure.

Authors:  C D Gove; R D Hughes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 6.  Nuclear trafficking of the epidermal growth factor receptor family membrane proteins.

Authors:  Y-N Wang; H Yamaguchi; J-M Hsu; M-C Hung
Journal:  Oncogene       Date:  2010-05-17       Impact factor: 9.867

7.  Studies on the hyperplasia ('regeneration') of the rat liver following partial hepatectomy. Changes in lipid peroxidation and general biochemical aspects.

Authors:  T F Slater; K H Cheeseman; C Benedetto; M Collins; S Emery; S P Maddix; J T Nodes; K Proudfoot; G W Burton; K U Ingold
Journal:  Biochem J       Date:  1990-01-01       Impact factor: 3.857

Review 8.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

9.  Effect of gastrin on liver regeneration after partial hepatectomy in rats.

Authors:  T N Rasmussen; P E Jørgensen; T Almdal; S S Poulsen; P S Olsen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

10.  Epidermal growth factor receptor targeted nuclear delivery and high-resolution whole cell X-ray imaging of Fe3O4@TiO2 nanoparticles in cancer cells.

Authors:  Ye Yuan; Si Chen; Tatjana Paunesku; Sophie Charlotte Gleber; William C Liu; Caroline B Doty; Rachel Mak; Junjing Deng; Qiaoling Jin; Barry Lai; Keith Brister; Claus Flachenecker; Chris Jacobsen; Stefan Vogt; Gayle E Woloschak
Journal:  ACS Nano       Date:  2013-11-27       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.